Element Capital Management LLC Incyte Corp Transaction History

Element Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$73.04 - $95.72 $1.57 Million - $2.06 Million	-21,510 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $1.57 Million - $1.86 Million	21,510 New	21,510 $1.6 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $1.49 Million - $1.8 Million	-20,295 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$63.56 - $88.17 $1.29 Million - $1.79 Million	20,295 New	20,295 $1.75 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $6.07 Million - $8.38 Million	-99,732 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $8.28 Million - $10.1 Million	99,732 New	99,732 $8.31 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.